Ozempic is not skinny privilege
It’s problematic when a woman on Ozempic talks about “thin privilege” while repeatedly saying “I’m skinny” because it sends mixed, harmful messages—even if she doesn’t intend to.
Here’s why it’s bad ?
1. It recenters the conversation on herself
Talking about privilege should shift focus away from the privileged person and toward people harmed by the system.
Repeatedly emphasizing “I’m skinny”:
- Pulls attention back to her body
- Turns a structural issue into personal validation
- Undermines the point she claims to be making
It becomes performative awareness, not real accountability.
2. It erases the role of medical and financial access
Ozempic isn’t just about willpower — it involves:
- Medical access
- Insurance or money
- Doctors willing to prescribe it
Calling herself “skinny” without consistently naming that medication + access played a role:
- Reinforces the myth that thinness = effort or virtue
- Makes others feel like failures for not achieving the same result
- Masks real privilege behind a “body positivity” shield
3. It reinforces thinness as the ultimate social currency
Even while talking about privilege, repeatedly asserting thinness subtly says:
“Being skinny still matters. It still defines me.”
That:
- Reaffirms thinness as a status symbol
- Contradicts the supposed critique of beauty standards
- Keeps fatphobia intact instead of challenging it
4. It harms people struggling with food, weight, or meds
For people who:
- Can’t access Ozempic
- Didn’t lose weight on it
- Regained weight
- Have eating disorders
This kind of messaging can:
- Trigger shame or comparison
- Make bodies feel like moral achievements
- Turn medication into a new hierarchy (“skinny and enlightened”)
5. It confuses honesty with humility
There’s a big difference between:
- Honest disclosure: “I lost weight with medical help, and that gives me social privilege.”
- Self-centering: “I’m skinny now” (repeatedly), while claiming to critique the system
The first builds trust.
The second builds resentment.